Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure

Recruiting

Early Phase 1

EmpagliflozinEffect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure

Sponsor:

University of Minnesota

Code:

NCT06507657

Conditions

Hypertension

Cardiovascular Diseases

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

empagliflozin

Placebo tablet

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by University of Minnesota on 2024-10-08.